ClinicalTrials.gg
Active, not recruitingNCT07267637ATBGUpdated Dec 5, 2025

Autogenous Tooth Bone Graft for Alveolar Socket Preservation

An interventional study of "Autogenous Tooth Bone Graft" in Alveolar Bone Grafting, Bone Regeneration Following Wisdom Teeth Extraction and Tooth Extraction Site Healing, sponsored by Haifaa Mohammed Al-hussini. Active, not recruiting at 1 site in Yemen. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-05.

Sponsored by Haifaa Mohammed Al-hussini · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jul 2024, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The purpose of this clinical experiment is to assess how well autogenous tooth bone grafting preserves the alveolar socket after surgical tooth extraction. Before being inserted into the socket, the graft is made from the patient's own extracted tooth and ground into a particle. Twenty Yemeni patients who needed their teeth extracted are included in the trial, and they will be followed up with clinical and radiographic procedures using cone-beam computed tomography (CBCT) for six months. The primary objective is to ascertain whether the autogenous dental bone graft can preserve the height, width, and density of alveolar bone, offering a secure, affordable, and biocompatible substitute for traditional grafting materials.

Read the detailed description

This interventional clinical study investigates the role of autogenous tooth bone graft in alveolar socket preservation after surgical tooth extraction. The extracted tooth is cleaned, dried, processed into particulate graft material manually using bone crusher, and disinfect and treated using (NaOH) and (Na CL). The graft particles are immediately placed into the fresh extraction socket and sutured. Twenty Yemeni patients requiring impacted lower third molar and upper canine teeth surgical extractions will be included. The healing process will be evaluated both clinically and radiographically over a 6-month period. Cone-beam computed tomography (CBCT) scans will be used to assess bone density and alveolar ridge dimensions before extraction and at six months' post-intervention. The study aims to determine whether autogenous tooth bone grafts can effectively reduce post-extraction alveolar bone resorption and maintain ridge dimensions, supporting their potential use as an autologous, biocompatible, and economically feasible graft material for clinical socket preservation.

02

Conditions studied

  • Alveolar Bone Grafting
  • Bone Regeneration Following Wisdom Teeth Extraction
  • Tooth Extraction Site Healing

Keywords

  • Autogenous Tooth Bone Graft
  • Socket Preservation
  • CBCT Imaging
  • Bone Density Measurement
  • Bone Regeneration in Dentistry
03

In context

Lead sponsor

This is the only study on the registry with Haifaa Mohammed Al-hussini as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - Absence of systemic diseases.
  • Very good to accepted oral hygiene.
  • Patients with impacted teeth requiring extraction.
  • Patients between the ages of 16 and 50.
  • No history of smoking.
  • No history of any other drug use.
  • Patients who were cooperative, motivated, to attend the follow-up and maintenance visits.

Exclusion criteria

Exclusion Criteria:

  • Systemic conditions or pharmacological therapies that could be an absolute for the intervention (such as un controlled diabetics, states, or treatment with oral or parenteral bisphosphonates).
  • Poor oral hygiene.
  • Acute exacerbation of chronic infection like pain or swelling.
  • Pregnant women, children, elderly (>60 years), physically and mentally challenged, terminally and seriously ill.
  • Hight Smoking tendency.
  • Patients who refused to participate in the trial.
  • Uncooperative Patients who won't be able to maintain the follow up visits
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Autogenous Tooth Bone Graft Intervention Group

    "In this arm of the study, participants will receive an autogenous tooth bone graft for alveolar socket preservation following surgical tooth extraction. The intervention involves the extraction of the patient's own tooth, which will be processed and used as a bone graft. This graft will be placed into the empty socket immediately after the extraction. The purpose of this intervention is to prevent bone resorption, promote natural healing, and support bone regeneration within the extraction site. CBCT scans will be performed before extraction to measure baseline bone dimensions and will be repeated 6 months post-intervention to assess the success of bone preservation in terms of height, width, and density."

    Biological: "Autogenous Tooth Bone Graft"

Interventions

  • Biological"Autogenous Tooth Bone Graft"

    "The intervention involves the use of the patient's own extracted tooth to create a bone graft for alveolar socket preservation following surgical tooth extraction. The patient's tooth is carefully processed to remove caries, periodontal ligaments, pulp, and any restorative materials, leaving behind a complete tooth structure (enamel, dentin, and cementum). This tooth is then crushed, disinfected, and treated before being placed into the empty socket. This graft helps maintain the structure of the alveolar bone by promoting natural bone regeneration and preventing resorption. The bone graft will be monitored for its efficacy in preserving alveolar bone height, width, and density, assessed using Cone Beam Computed Tomography (CBCT)."

06

What researchers measure

Primary outcomes

  1. "Alveolar Bone Height, Width, and Density Preservation with Autogenous Tooth Bone Graft"

    This study aims to evaluate the effectiveness of autogenous tooth bone grafts in preserving alveolar bone following tooth extraction. The study will assess changes in alveolar bone height, width, and density using Cone Beam Computed Tomography (CBCT) at two time points: before extraction (baseline) and 6 months post-grafting. The outcome measures are: Alveolar Bone Height: Measured in millimeters using CBCT at baseline and 6 months. Alveolar Bone Width: Measured in millimeters using CBCT at baseline and 6 months. Alveolar Bone Density: Measured in Hounsfield units using CBCT at both time points. The intervention involves using the patient's own extracted tooth to create a bone graft placed into the socket, promoting healing and bone regeneration. This study will determine the effectiveness of autogenous tooth bone grafts in preventing bone resorption and preserving alveolar socket structure.

    Time frame: "Before extraction and 6 months post-intervention"

07

Study locations

1 site
  • Sana'a University faculty of Dentisrty
    Sanaa, Sanaa Governorate, Yemen
08

References and documents

Publications

  • Valdec S, Pasic P, Soltermann A, Thoma D, Stadlinger B, Rucker M. Alveolar ridge preservation with autologous particulated dentin-a case series. Int J Implant Dent. 2017 Dec;3(1):12. doi: 10.1186/s40729-017-0071-9. Epub 2017 Mar 30. PubMed 28361377 ↗
  • Mahardawi B, Damrongsirirat N, Dhanesuan K, Subbalekha K, Mattheos N, Pimkhaokham A. Radiographic changes after alveolar ridge preservation using autogenous raw tooth particles versus xenograft: A prospective controlled clinical trial. Clin Oral Implants Res. 2024 Dec;35(12):1597-1606. doi: 10.1111/clr.14348. Epub 2024 Aug 12. PubMed 39132806 ↗

Individual participant data

Plan to share: Yes — "We will share anonymized individual participant data (IPD), including baseline characteristics, clinical assessments, and key outcome measures (alveolar bone height, width, and density) collected before and after the autogenous tooth bone graft intervention. Access to the data will be granted to qualified researchers who meet the criteria for data sharing and comply with the applicable data use agreement."

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: "IPD and supporting information will be made available starting 12 months after the completion of the study. The data will be accessible for a period of 5 years."

Access criteria: "Access to IPD and supporting information will be granted to qualified researchers who submit a data request via the ClinicalTrials.gov platform. Researchers must meet the criteria outlined in the Data Use Agreement, which ensures that the data will be used responsibly and for research purposes only."

Data sharing details ↗ · clinicaltrials.gov

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2024 to primary completion in Nov 2025, 15 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 23, 2025
First posted
Dec 5, 2025
StartActual
Jul 14, 2024
Primary completionActual
Nov 1, 2025
CompletionEst.
Aug 31, 2026
Last update
Dec 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07267637
Lead sponsor
Haifaa Mohammed Al-hussini
Responsible party
Haifaa Mohammed Al-hussini ("Principal Investigator, Haifaa Al-Hussini, BDS, MSc Candidate, Sana'a University", Sana'a University) — Sponsor-investigator
First posted
Dec 5, 2025
Start date
Jul 14, 2024
Primary completion
Nov 1, 2025
Completion
Aug 31, 2026 (estimated)
Last update
Dec 5, 2025

Study contacts

Haifaa Alhussini, BDS, MSc
principal investigator · Sana'a University Faculty of Dentistry

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion